Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03338569Phase 3Completed
A Phase 3 trial of ascorbic acid in septic shock, sponsored by University of Minnesota. Started Dec 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03338569.